LGVN
LGVN
NASDAQ · Biotechnology

Longeveron Inc-A

$2.63
-0.18 (-6.41%)
As of Sep 28, 10:41 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +952.9% upside
Low Target $21.92
Average Target $27.69
High Target $40.08
Current Price $2.63
Current
$2.63
Target
$27.69
$21.92 $27.69 avg $40.08
Scenario Analysis
Bear Case
$21.92
733.5%
Low target
Base Case
$27.69
+952.9%
Avg target
Bull Case
$40.08
+1,424.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$12.30
-78.6% from high
52-Week Low
$2.30
+14.3% from low
Target vs 52W High
$27.69
+125.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%